Naftidrofuryl (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C04AX21
CAS registry number (Chemical Abstracts Service)
0031329-57-4
Chemical Formula
C24-H33-N-O3
Molecular Weight
384
Therapeutic Category
Peripheral vasodilator
Chemical Name
2-Furanpropanoic acid, tetrahydro-α-(1-naphtalenylmetyl)-, 2-(dietylamino)etyl ester
Foreign Names
- Naftidrofurylum (Latin)
- Naftidrofuryl (German)
- Naftidrofuryl (French)
- Naftidrofurilo (Spanish)
Generic Names
- Naftidrofurile (OS: DCIT)
- Naftidrofuryl (OS: BAN, DCF)
- EU-1806 (IS)
- LS 121 (IS)
- Nafronyl (IS)
- Nafronyl Oxalate (OS: USAN)
- Naftidrofuryl Oxalate (OS: BANM, JAN)
- Naftidrofuryl (oxalate acide de) (PH: Ph. Eur. 9)
- Naftidrofuryl hydrogen oxalate (PH: Ph. Eur. 9)
- Naftidrofuryl hydrogenoxalat (PH: Ph. Eur. 9)
- Naftidrofuryl Oxalate (PH: BP 2018)
- Naftidrofuryli hydrogenooxalas (PH: Ph. Eur. 9)
Brand Names
- Cerebromap
Apex, Egypt - Clarantin
Medochemie, Tunisia - Naftilong 200 mg retard
Hexal, Hungary - Naftor
ACT Pharma, Tunisia - Praxilene
Lipha Sante, Lebanon; Merck, Egypt; Merck Santé, Tunisia - Cirpril
Kwang Dong, South Korea - Clarantin
Medochemie, Cyprus - Diactane
Menarini, France - Drosunal
Balkanpharma-Dupnitsa, Bulgaria - Dusodril
Merck Sante, Romania; Merck Serono, Germany - Dusodril 100mg
Famar L'Aigle, Bulgaria - Dusodril 200mg
Famar Lyon, Bulgaria; Merck S.L., Bulgaria - Dusodril forte
Merck Serono, Germany - Dusodril retard
Merck Serono, Germany - Dusodril retard 100 mg
Merck, Austria - Dusodril retard 200 mg
Merck, Austria - Dusopharm
Unipharm, Bulgaria - Enelbin
Zentiva, Latvia - Enelbin retard
STADA, Slovakia; Zentiva, Czech Republic; Zentiva, Estonia - Frilix
Pharos, Indonesia - Iridus
Sanofi-Aventis, Mexico; Sanofi-Aventis, Venezuela - Nafly
Samil, South Korea - Nafoxal
Sandoz, Indonesia - Nafril
Hanall Biopharma, South Korea - Nafti-CT
AbZ-Pharma, Germany - Naftidrofuryl
Actavis UK, United Kingdom - Naftidrofuryl Biogaran
Biogaran, France - Naftidrofuryl EG
EG Labo, France - Naftidrofuryl Mylan
Mylan, France - Naftidrofuryl Ranbaxy
Ranbaxy, France - Naftidrofuryl Teva
Teva Santé, France - Naftidrofuryl Zentiva
Sanofi-Aventis, France - Naftilong
Hexal, Germany - Naftilong 100 mg retard
Hexal, Hungary - Naftilux
Thérabel Lucien, France - Nafti-ratiopharm
ratiopharm, Germany - Praxilene
Alapis A.B.E.E., Greece; Faes, Spain; Formenti, Italy; Lipha, Kuwait; Merck, Hong Kong; Merck, Indonesia; Merck, Portugal; Merck Consumer Healthcare, Belgium; Merck Serono, France; Merck Serono, United Kingdom; Merck Serono, Ireland; Merck Merck Serono Division, Singapore - Praxilene 200mg
Merck, Switzerland; Merck, Luxembourg; Merck KGaA, Vietnam - Vascuprax
Ikapharmindo, Indonesia; Lipha, Indonesia
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.